Drug Shortage Report for TEVA-CANDESARTAN/HCTZ

Last updated on 2024-02-22 History
Report ID 206425
Drug Identification Number 02395568
Brand name TEVA-CANDESARTAN/HCTZ
Common or Proper name CANDESARTAN/HCTZ 32/12.5MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 32MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size PP
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-24
Estimated end date 2024-04-10
Actual end date
Shortage status Actual shortage
Updated date 2024-02-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-02-22 French Compare
v15 2024-02-22 English Compare
v14 2024-02-15 French Compare
v13 2024-02-15 English Compare
v12 2024-02-12 French Compare
v11 2024-02-12 English Compare
v10 2024-02-08 French Compare
v9 2024-02-08 English Compare
v8 2023-11-09 French Compare
v7 2023-11-09 English Compare
v6 2023-11-03 French Compare
v5 2023-11-03 English Compare
v4 2023-10-12 French Compare
v3 2023-10-12 English Compare
v2 2023-10-05 French Compare
v1 2023-10-05 English Compare

Showing 1 to 16 of 16